Impact of relative dose intensity of standard regimens on survival in elderly patients aged 80 years and older with diffuse large B-cell lymphoma

Haematologica. 2020 Aug;105(8):e415-e418. doi: 10.3324/haematol.2019.234435. Epub 2020 Jan 9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Prednisone / therapeutic use
  • Reference Standards
  • Rituximab / therapeutic use
  • Treatment Outcome
  • Vincristine / therapeutic use

Substances

  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone